FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064118966> ?p ?o ?g. }

• W2064118966 endingPage "167" @default.
• W2064118966 startingPage "157" @default.
• W2064118966 abstract "Our purpose was to analyze (1) the effects of prevalent lower reproductive tract infections and (2) the effect of systematic diagnosis and treatment to reduce risks of early pregnancy loss (< 22 weeks), preterm premature rupture of membrances, and overall preterm birth.A prospective, controlled treatment trial was conducted on 1260 women. During the first 7 months of the program (observation, phase I), women were examined at initiation of prenatal care for a panel of lower genital tract microorganisms and bacterial vaginosis. Women were followed up with reexaminations at 22 to 29 weeks and after 32 weeks' gestation. The recommended treatments of the Centers for Disease Control (i.e., 300 mg of clindamycin orally twice daily for 7 days for bacterial vaginosis) were used for infected women during the second 8 months of the study (treatment, phase II). Data were analyzed according to intent to treat by means of univariate and multivariate methods.Overall, presence of bacterial vaginosis (32.5%) at enrollment was associated with pregnancy loss at < 22 weeks' gestation (relative risk 3.1, 95% confidence interval 1.4 to 6.9). Among women in the observation phase bacterial vaginosis was associated with increased risk of both preterm birth (relative risk 1.9, 95% confidence interval 1.2 to 3.0) and preterm premature rupture of membranes (relative risk 3.5, 95% confidence interval 1.4 to 8.9). Within this population (phase I) 21.9% of preterm birth overall (43.8% premature rupture of membranes) is estimated as attributable to bacterial vaginosis. Among women with bacterial vaginosis phase II (treatment) was associated with reduced preterm birth (relative risk 0.5, 95% confidence interval 0.3 to 0.9); there was a similar reduction for women with preterm premature rupture of membranes (relative risk 0.5, 95% confidence interval 0.2 to 1.4). Women with both bacterial vaginosis and trichomoniasis were at highest risk of preterm birth (28%); treatment of both conditions (phase II) reduced preterm birth (17%) but did not eliminate this risk. Earlier patient enrollment and oral antibiotic treatment were associated with reduced preterm birth.This prospective, controlled trial confirms that the presence of bacterial vaginosis is associated with increased risks of pregnancy loss at < 22 weeks, preterm premature rupture of membranes, and preterm birth. Orally administered clindamycin treatment is associated with a 50% reduction of bacterial vaginosis-linked preterm birth and preterm premature rupture of membranes. Women at risk for preterm birth or preterm premature rupture of membranes because of bacterial vaginosis or common genital tract infections should be screened, treated, reevaluated for cure, and re-treated if necessary." @default.
• W2064118966 created "2016-06-24" @default.
• W2064118966 creator A5025753610 @default.
• W2064118966 creator A5029982665 @default.
• W2064118966 creator A5046398969 @default.
• W2064118966 creator A5057155990 @default.
• W2064118966 creator A5062005062 @default.
• W2064118966 creator A5076440599 @default.
• W2064118966 creator A5083862586 @default.
• W2064118966 creator A5089975178 @default.
• W2064118966 date "1995-07-01" @default.
• W2064118966 modified "2023-10-14" @default.
• W2064118966 title "Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation" @default.
• W2064118966 cites W1856671815 @default.
• W2064118966 cites W1972809230 @default.
• W2064118966 cites W1985142615 @default.
• W2064118966 cites W1985659402 @default.
• W2064118966 cites W1991191872 @default.
• W2064118966 cites W1992823394 @default.
• W2064118966 cites W1994899554 @default.
• W2064118966 cites W2011692789 @default.
• W2064118966 cites W2018924651 @default.
• W2064118966 cites W2020530888 @default.
• W2064118966 cites W2030192997 @default.
• W2064118966 cites W2043814908 @default.
• W2064118966 cites W2047672659 @default.
• W2064118966 cites W2051905908 @default.
• W2064118966 cites W2053346041 @default.
• W2064118966 cites W2074261957 @default.
• W2064118966 cites W2089194502 @default.
• W2064118966 cites W2144926538 @default.
• W2064118966 cites W2154296030 @default.
• W2064118966 cites W2394498514 @default.
• W2064118966 cites W4376849391 @default.
• W2064118966 doi "https://doi.org/10.1016/0002-9378(95)90184-1" @default.
• W2064118966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7631673" @default.
• W2064118966 hasPublicationYear "1995" @default.
• W2064118966 type Work @default.
• W2064118966 sameAs 2064118966 @default.
• W2064118966 citedByCount "342" @default.
• W2064118966 countsByYear W20641189662012 @default.
• W2064118966 countsByYear W20641189662013 @default.
• W2064118966 countsByYear W20641189662014 @default.
• W2064118966 countsByYear W20641189662015 @default.
• W2064118966 countsByYear W20641189662016 @default.
• W2064118966 countsByYear W20641189662017 @default.
• W2064118966 countsByYear W20641189662018 @default.
• W2064118966 countsByYear W20641189662019 @default.
• W2064118966 countsByYear W20641189662020 @default.
• W2064118966 countsByYear W20641189662021 @default.
• W2064118966 countsByYear W20641189662022 @default.
• W2064118966 countsByYear W20641189662023 @default.
• W2064118966 crossrefType "journal-article" @default.
• W2064118966 hasAuthorship W2064118966A5025753610 @default.
• W2064118966 hasAuthorship W2064118966A5029982665 @default.
• W2064118966 hasAuthorship W2064118966A5046398969 @default.
• W2064118966 hasAuthorship W2064118966A5057155990 @default.
• W2064118966 hasAuthorship W2064118966A5062005062 @default.
• W2064118966 hasAuthorship W2064118966A5076440599 @default.
• W2064118966 hasAuthorship W2064118966A5083862586 @default.
• W2064118966 hasAuthorship W2064118966A5089975178 @default.
• W2064118966 hasConcept C126322002 @default.
• W2064118966 hasConcept C131872663 @default.
• W2064118966 hasConcept C188816634 @default.
• W2064118966 hasConcept C2776344615 @default.
• W2064118966 hasConcept C2777102558 @default.
• W2064118966 hasConcept C2779234561 @default.
• W2064118966 hasConcept C2779952448 @default.
• W2064118966 hasConcept C2908647359 @default.
• W2064118966 hasConcept C29456083 @default.
• W2064118966 hasConcept C44249647 @default.
• W2064118966 hasConcept C46973012 @default.
• W2064118966 hasConcept C54355233 @default.
• W2064118966 hasConcept C71924100 @default.
• W2064118966 hasConcept C82789193 @default.
• W2064118966 hasConcept C86803240 @default.
• W2064118966 hasConcept C99454951 @default.
• W2064118966 hasConceptScore W2064118966C126322002 @default.
• W2064118966 hasConceptScore W2064118966C131872663 @default.
• W2064118966 hasConceptScore W2064118966C188816634 @default.
• W2064118966 hasConceptScore W2064118966C2776344615 @default.
• W2064118966 hasConceptScore W2064118966C2777102558 @default.
• W2064118966 hasConceptScore W2064118966C2779234561 @default.
• W2064118966 hasConceptScore W2064118966C2779952448 @default.
• W2064118966 hasConceptScore W2064118966C2908647359 @default.
• W2064118966 hasConceptScore W2064118966C29456083 @default.
• W2064118966 hasConceptScore W2064118966C44249647 @default.
• W2064118966 hasConceptScore W2064118966C46973012 @default.
• W2064118966 hasConceptScore W2064118966C54355233 @default.
• W2064118966 hasConceptScore W2064118966C71924100 @default.
• W2064118966 hasConceptScore W2064118966C82789193 @default.
• W2064118966 hasConceptScore W2064118966C86803240 @default.
• W2064118966 hasConceptScore W2064118966C99454951 @default.
• W2064118966 hasIssue "1" @default.
• W2064118966 hasLocation W20641189661 @default.
• W2064118966 hasLocation W20641189662 @default.
• W2064118966 hasOpenAccess W2064118966 @default.
• W2064118966 hasPrimaryLocation W20641189661 @default.

• next